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ABSTRACT
Motivation: The T-cell receptor, a major histocompatibility
complex (MHC) molecule, and a bound antigenic peptide, play
major roles in the process of antigen-specific T-cell activation.
T-cell recognition was long considered exquisitely specific.
Recent data also indicate that it is highly flexible, and one
receptor may recognize thousands of different peptides. Deci-
phering the patterns of peptides that elicit a MHC restricted
T-cell response is critical for vaccine development.
Results: For the first time we develop a support vector
machine (SVM) for T-cell epitope prediction with an MHC type I
restricted T-cell clone. Using cross-validation, we demon-
strate that SVMs can be trained on relatively small data sets
to provide prediction more accurate than those based on
previously published methods or on MHC binding.
Contact: rsimon@mail.nih.gov
Supplementary information: Data for 203 synthesized
peptides is available at http://linus.nci.nih.gov/Data/
LAU203_Peptide.pdf
INTRODUCTION
Peptides degraded from foreign or self-proteins bind to
major histocompatibility complex (MHC) molecules. The
MHC–peptide complex can be recognized by T-cell recept-
ors and trigger an immune response. Identifying character-
istic patterns of immunogenic peptide epitopes can provide
fundamental information for understanding disease patho-
genesis and etiology, and for therapeutics such as vaccine
development.
Due to the complexity of the tri-molecular complex (pep-
tide, MHC molecule, and T-cell receptor), early studies
focused on the interaction between peptide and MHC. Struc-
tural studies and systematic binding analyses have provided
∗To whom correspondence should be addressed.
insight into the peptide binding patterns to MHC (Engelhard,
1994; Madden, 1995; Rothbard and Gefter, 1991; Sette et al.,
1994). Mathematical approaches including binding motifs
(Hammer et al., 1993; Hammer, 1995; Rammensee et al.,
1995; Sette et al., 1989), quantitative matrices (Parker et al.,
1994; Southwood et al., 1998; Sturniolo et al., 1999), artifi-
cial neural networks (ANNs) (Brusic et al., 1998; Gulukota
et al., 1997; Milik et al., 1998), and support vector machines
(SVMs) (Dönnes and Elofsson, 2002) used to model these
interactions have led to an increasingly more refined under-
standing of MHC/peptide binding.
MHC binders are not always T-cell epitopes however.
Efforts to predict candidate T-cell epitopes have been util-
ized ANNs (Honeyman et al., 1998). A full ANN with an
indicator for each amino acid at each position requires 200
input nodes (20 amino acids ×10 positions). Large ANNs
require very large amounts of data to avoid obtaining poor
predictions resulting from over-fitting a limited set of train-
ing data (Rumelhart et al., 1986). The number of weights for
edges joining m input nodes to h hidden layer nodes is h×m.
Hence even with only h = 2, a prohibitive amount of data is
required for properly training a network with 402 parameters.
To generate such an extensive amount of data for a single TCR
is very expensive. Accurate modeling strategies that are more
efficient in use of TCR proliferation assay data and antigen
recognition data are needed.
In recent years, various pattern recognition techniques have
been applied in biology. SVMs are one of the most powerful
new techniques and have been effective in DNA sequence ana-
lysis, protein structure prediction and gene expression pattern
discovery (Brown et al., 2000; Furey et al., 2000; Guyon et al.,
2002; Hua and Su, 2001; Zien et al., 2000; Ding et al., 2001;
Zavalijevski et al., 2002). SVMs are particularly appealing
for T-cell epitope prediction because of the ability of SVMs
to build effective predictive models when the dimensionality
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Fig. 1. Pairwise comparison of the peptides in positive (a) and negative (b) groups. Pearson correlation coefficients were calculated for all
pairs in each group using 10 physical factors in 10 positions.
of the data is high and the number of observations is lim-
ited. SVMs are based on a strong theoretical foundation for
avoiding over-fitting training data and they do not have the
problem of the numerous local optimal that limit ANN models
(Vapnik, 1995).
We analyzed our relatively small data set by building a
SVM. This is the first time a SVM has been used for T-cell
epitope prediction.
SYSTEM AND METHODS
T-cell clone and antigen recognition assay
Melan-A-specific CTL clone LAU203-1.5 was derived from
tumor-infiltrated lymph node cells of a melanoma patient and
antigen recognition was assessed using a chromium-release
assay as previously described (Valmori et al., 1998).
Peptide synthesis and test
Peptides were synthesized by the simultaneous-multiple-
peptide-synthesis methods (Pinilla et al., 1994) and charac-
terized using HPLC and mass spectrometry.
LAU203-1.5 is an A∗0201 restricted T-cell clone (TCC)
from tumor-infiltrated lymph node cells of a melanoma
patient. 203 synthetic peptides were selected based on res-
ults using single- and multiple-amino acid-substitutions and
combinatorial peptide library experiments with a chromium
release antigen recognition assay (Rubio-Godoy et al., 2002).
These peptides were tested against the LAU203-1.5 clone
using the same assay. A peptide with percentage specific lysis
higher than 10% was considered positive.
Training and test data sets
Due to the imbalance of two classes in the data set (36 stim-
ulatory peptides and 167 non-stimulatory peptides), we first
divided the data into positive and negative groups. Then in
each group random sampling was used to select 80% of the
total peptides for training and 20% as a test set. Finally
the positive and negative groups were combined separately
in the training and test sets. This procedure was repeated
independently 10 times.
Each amino acid in a peptide was encoded by ten factors.
These orthogonal factors were obtained from 188 physical
properties of 20 amino acids via multivariate statistical ana-
lyses by Scheraga’s group (Kidera et al., 1985). They account
for 86% of the variance of the 188 physical properties. These
factors included alpha-helix or bend-structure preference,
bulk, beta-structure preference, hydrophobicity, normalized
frequency of double bend, normalized frequency of alpha-
region, and pK-C. This encoding reduces the dimension of
predictors by half while enabling structural and biophysical
properties to be better represented compared to using amino
acid indicator variables. Since our peptides are all 10-mers,
the total number of input variables is 100.
To ensure that the peptides were sufficiently dissimilar for
the cross-validation to be valid, we calculated the pairwise
Pearson correlation coefficients for all positive peptides and
negative peptides. Figure 1 shows the histograms of the cor-
relation coefficients in each group. Only 5% in the positive
group and 1% in the negative group have correlations larger
than 0.6.
Training a support vector machine
SVM training was performed using SVMlight (version 4.0)
(Joachim, 1999). There were 100 input variables, which rep-
resent the ten positions in the peptide. The class values were
set to 1 for positive peptides and −1 for negative peptides.
The threshold to predict positive or negative peptide was set
to 0 by default.
For two group classification, SVM separates the classes
with a surface that maximizes the margin between them.
It is an approximate implementation of the Structural Risk
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Minimization induction principle, which attempts to minim-
ize with the generalization error for independent data rather
than minimizing the mean square error for the training set
(Vapnik, 1995).
SVM classification of a sample with a vector x of predictors
is based on:
f (x) = sign
(∑
i
yiαik(xi , x) + b
)
where the kernel function k( , ) measures the similarity of
its two vector arguments. For linear SVM, the inner product
kernel function is used. If f (x) is positive, then the sample is
predicted to be in class +1; otherwise class −1. The sum-
mation is over the set of ‘support vectors’ that define the
boundary between the classes. Support vector xi is associ-
ated with a class label yi that is either +1 or −1. The {αi} and
b coefficients are determined by ‘learning’ the data.
For each training set consisting of 80% of the observa-
tions, a fully specified linear SVM was developed. This SVM
model was then applied to the 20% test set. During learn-
ing on the 80% training set, leave-one-out cross-validation
was employed to automatically optimize the relative misclas-
sification costs for the two classes and to optimize the tuning
parameter that reflects the trade-off between the training error
and class separation. This leave-one-out process only utilized
data from the 80% training set.
Training and testing were repeated ten times for randomly
determined training/test set partitions. The final indexes were
averaged over the ten replicates.
ANN and Decision Tree Classifiers
The same training/test set partitions used for SVM ana-
lyses were also used for building and evaluating ANN and
Decision Tree classifiers. The same input vector encoding was
also used. The neural network analysis was performed using
the Neuroshell 2 software package (Ward Systems Group).
We chose a feed-forward architecture with three layers (single
hidden layer). There were 100 neurons in the input layer and
two neurons in the hidden layer. Each SVM training set was
separated into training set and control set at a 9 to 1 ratio. The
control set was used for controlling ANN training. The ANN
production set was the same as the SVM test set. The learn-
ing rate and momentum were both set to 0.1, and the learning
epoch was 2000. The threshold to predict positive or negative
peptide was set to 0 by default.
The classification trees were generated using the Classifica-
tion and Regression Tree approach (Breiman et al., 1984)
implemented in S-plus 2000 software. The predictors were the
same as the SVM input. The responses were set to 1 for pos-
itive peptides and 0 for negative peptides. We used the same
data sets generated for SVM. Ten-fold cross-validation within
each training set was used for optimally pruning the trees.
A∗0201 peptide-binding based predictions
SYFPEITHI is a profile based method to predict MHC bind-
ing peptides (Rammensee et al., 1999). Thirteen different
MHC class I types of binding peptides can be predicted.
It is publicly available through a website (http://syfpeithi.
bmi-heidelberg.com/Scripts /MHCServer.dll/EpPredict.htm).
A∗0201 was used to predict all 203 melanoma clone LAU203-
1.5 peptides. The threshold between binders and non-binders
was optimized.
SVMHC is based on SVM to predict the binding of
peptides to MHC type I molecules (Dönnes and Elofsson,
2002). It contains prediction for 26 MHC class I type
from the MHCPEP database and 6 MHC class I types
from the SYFPEITHI database. It can be publicly accessed
(http://www.sbc.su.se/svmhc/). A∗0201 was used to predict
all 203 melanoma clone LAU203-1.5 peptides. The threshold
between binders and non-binders was kept as zero by default.
RESULTS
Since identifying stimulatory (positive) peptides is of greatest
concern, sensitivity and positive predictive value (PPV) were
used to evaluate the models. Sensitivity is the portion of all
positive peptides that are correctly identified. PPV is the prob-
ability that a peptide predicted to be positive actually does
stimulate the TCC. Sensitivity indicates the ability of the
classifier to detect real epitopes whereas PPV reflects the effi-
ciency of the method. A classifier with low PPV will result in
the generation of numerous non-stimulatory peptides for the
next rounds of testing.
Table 1 shows the performance of the SVM for the 10 test
sets. The average cross-validated sensitivity and PPV were
76.3 and 71.6%, respectively, for the 10 test sets. An aver-
aged ROC curve (Swets, 1988) was also determined based on
applying SVM models to the 10 different test sets (Table 2).
The area under the averaged ROC curve was 0.919 (Fig. 2).
ANN models were optimized by modifying the learning
rate and momentum. The optimized models gave an average
sensitivity of 55.0% and PPV of 81.7% on the 10 test sets
(Table 2). Decision tree classifiers gave an average sensitivity
of 46.3% and PPV of 86.7% for the same ten test sets (Table 2).
In order to compare with other MHC-binding based predic-
tions, we applied both SVMHC and SYFPEITHI to predict
all 203 synthetic peptides of melanoma clone LAU203-1.5.
For SVMHC based on training data from the SYFPEITHI
database, the sensitivity was 30.6% and PPV was 45.8%.
For SVMHC based on training data from the MHCPEP data-
base, the sensitivity was 38.9% and PPV was 45.1%. For
SYFPEITHI, the sensitivity was 86.1% and PPV was 34.8%
(Table 2).
Among the 203 synthesized peptides, 105 peptides were
predicted with high scores using the score matrix based
approach (Zhao et al., 2001) and were selected as positive
peptides for synthesis. None of the remaining 98 unrelated
1980
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Table 1. Cross-validation of SVM models in the 10 test sets (42 peptides)
Test Set Sensitivity PPV
1 4/8 4/7
2 7/8 7/9
3 7/8 7/9
4 5/8 5/6
5 6/8 6/7
6 5/8 5/6
7 6/8 6/11
8 5/8 5/8
9 8/8 8/13
10 8/8 8/11
Table 2. Comparison of SVM performance to other methods
Method Sensitivity PPV
SVM 0.763 0.716
ANN 0.550 0.817
Decision tree 0.463 0.867
Score matrixa 1.000 0.343
SYFPEITHI 0.863 0.348
SVMHC (a)b 0.306 0.458
SVMHC (b)c 0.389 0.451
aThe analysis was based on an approach using a Z-matrix as described (Zhao et al.,
2001).
bThe SVM model was trained based on A∗0201 restricted MHC binding data from
SYFPEITHI database.
cThe SVM model was trained based on A∗0201 restricted MHC binding data from
MHCPEP database.
peptides was significantly recognized by TCR and all of them
were predicted to have relative low scores. This translated the
sensitivity and the PPV of the score matrix based approach
to 100 and 34.3%, respectively (Table 2). The area under the
ROC curve was 0.833 (Fig. 2).
DISCUSSION
The ANN and decision tree classifiers had slightly better posit-
ive predictive values than the SVM but their sensitivities were
substantially lower. The ANN model had many more paramet-
ers than the SVM and probably requires a larger number of
training peptides for equivalent performance. The ANN model
was more difficult to fit and optimize because of the number
of parameters. Although the threshold distinguishing stimu-
latory and non-stimulatory peptides can be shifted to increase
the sensitivity, the specificity and the PPV will suffer corres-
ponding decreases. For our data set, the ratio of the numbers
of peptides in two classes is about 1 : 5. A small reduction of
specificity will lead to a much larger reduction of PPV.
Decision tree classifiers are attractive because they are easily
interpretable. There are many kinds of decision tree classifiers,
with considerable arbitrariness in the criteria for determining
the variables and cut-points used for splits. Decision tree clas-
sifiers are data-greedy; each split partitions the data into dis-
joint subsets which are then analyzed separately to determine
Fig. 2. ROC comparison of SVM to score matrix based approach.
their next splits. It is easy to over-fit decision tree classifiers
and such models require large training sets. The Classifica-
tion and Regression Tree methodology that we used employs
cross-validation within the training set to optimally prune the
tree and avoid over-fitting. Nevertheless, the optimal decision
tree classifier had a sensitivity considerably less than the SVM.
Selection of input variables, a suitable kernel, and optimal
learning parameters play key roles in developing SVMs. We
examined different types of input variables for predicting
TCR epitopes. We first used indicators for the 20 amino acids
(1 present or 0 absent) at each position of the 10-mer pep-
tide. The second set of variables we evaluated was based on
use of the amino acid substitution matrices such as Blossum
(Henikoff and Henikoff, 1992) or PAM (Dayhoff et al., 1978).
In this case, each amino acid was encoded by numerical value
representing its distance from Alanine. Both types of inputs
gave considerably poorer results than using the ten principal
factors as inputs.
We found that the simple linear kernel performed best in our
data set, compared to the polynomial and radial basis kernel
functions. This is not surprising since the VC dimension is
lower with a linear kernel (Vapnik, 1995) and hence general-
ization performance with limited training data is likely to be
better.
Often the tuning parameters for SVM learning are chosen
somewhat arbitrarily. We used a leave-one-out cross-
validation imbedded in the training set to select the tun-
ing parameters optimally. Leave-one-out cross-validation
was employed to optimize the two tuning parameters:
(i) the relative misclassification costs for the two classes and
(ii) the trade-off between the training error and class separa-
tion. This cross-validation was performed entirely within the
training set.
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TCR ligands are not always high affinity MHC binders, and
only a fraction of the potential MHC-binding peptides is a
T-cell epitope for a specified TCR. Approaches to identify
T-cell epitopes based on the prediction of which peptides
would be good binders for specific MHC molecules are not
accurate, since a functional T-cell response requires adequate
MHC–peptide binding as well as proper interaction of the
MHC–peptide ligand with a specific TCR. The comparisons
clearly show our SVM approach to predict T-cell epitopes is
superior to the publicly available methods such as SVMHC
and SYFPEITHI (Table 2).
Previously, we reported a novel approach using biometric
score matrix combined with combinatorial peptide libraries
to predict T-cell epitope candidates (Zhao et al., 2001). That
approach is based on a simple linear model under the assump-
tion of independent contribution of side chains of amino acid
within the peptide whereas the assumption of largely inde-
pendent contributions of individual amino acids to stimulation
seems to be a reasonably good approximation. Interactions of
adjacent amino acids also exist and their effect may not always
be predicted on the basis of individual substitutions (Leggatt
et al., 1998; Hemmer et al., 1999, 2000). In addition, physico-
chemical characteristics of individual amino acids can change
the HLA binding register. SVMs provide a framework for
more sophisticated models that can take into account the inter-
actions among the numerous factors that may influence T-cell
recognition, and thereby accelerate the process of finding
T-cell epitopes. Comparison of ROCs between SVM approach
and score matrix based approach clearly indicates the SVM
model greatly improves the prediction accuracy (Fig. 2 and
Table 2).
Antigenic synthetic decapeptide Melan-A26–35
(EAAGIGILTV) was predicted to be a T-cell epitope by our
SVM model. It was strongly stimulatory, being among the
peptides with highest percentage of specific lysis. We did in
silico single amino acid substitution at all positions and used
the SVM model to predict the activity of the mutated pep-
tides. For A∗0201, position 2 and 9/10 are considered to be
the putative MHC anchors (Rammensee et al., 1995). Sub-
stitution of Thr in position 9 with hydrophobic residues Phe,
Leu and Ile yielded the highest SVM scores while substitu-
tion of Val increased the SVM score slightly. At position 10,
hydrophobic residues Val, Leu, and Ile were the only ones to
keep the SVM unchanged; other substitutions would lead to
either a reduced positive SVM score or even a negative SVM
score. This is somewhat consistent with the A∗0201 binding
motif. When we examined the score matrix generated from
combinatorial peptide library data, the above three residues
did not have the highest scores at position 9; the matrix scores
of Leu and Ile were well below the average. At position 2, Cys,
Arg, Glu, Met, and Thr yielded higher SVM scores while Leu
kept almost the same score as Ala in the template. Some of
the above residues do not appear in the MHC anchor motif
at position 2. Of interest, Met yielded a higher SVM score
than Thr. Previous report had showed that replacing a Thr
with a Met at the second position of gp100 epitope g209-217
(ITDQVPFSV) altered the binding affinity of the peptide to
the HLA-A2 molecule and led to an increased recognition
of the MHC–peptide complex by the TCR (Parkhurst et al.,
1996). On the other hand, substitution with polar residues
Ser, Thr, and Asn at position 2 would yield negative SVM
scores. Residues at position 4–8 were suggested to be primar-
ily involved in TCR recognition (Parkhurst et al., 1996). Gly,
the simplest amino acid with no side chain, was the only amino
acid to be allowed at position 6 in order to keep the peptide
to be predicted positive, while at the same position the non-
polar residue Proline was the least favored one and yielded
the lowest negative SVM score. Hydrophobic residues were
favored at position 5 (Ile, Phe, Ala, Val) and 7 (Ala, Ile, Leu,
Val), while replacing Leu with hydrophobic residues Phe or
Ile at position 8 would lead to 1.5- to 2-fold increase of SVM
scores. At position 4, Arg, Ser, and Thr doubled the SVM
scores compared to Ala in the template.
Finally, in order to help interpret the SVM predictions for
the single residue substitutions of the synthetic decapeptide
(EAAGIGILTV), we calculated the Pearson correlation coef-
ficients for each of the 494 physical properties listed in
the public database (http://www.genome.ad.jp/dbget/aaindex.
html) against the SVM scores of 20 mutants in each position.
Several physical properties were highly correlated (|r| > 0.7)
with positions 4, 5, 6, 7, 9, and 10. For example, we found
that position 9 was highly correlated with van der Waals para-
meter R0 and position 7 was correlated with partial specific
volume. Positions 5 and 7 were all correlated with normal-
ized frequency of beta-sheet while position 6 was negatively
correlated with normalized relative frequency of helix end.
Our results suggest that SVMs can be effectively used for
predicting T-cell epitopes. Using physical property factors
to encode the candidate peptides enables SVM classifiers to
achieve good performance with modest amounts of synthes-
ized peptide training data. This makes for an efficient process
of prediction and synthesis of additional peptides because
positive peptides are most informative. The SVM predictor
can be used to provide information about the nature of the
tri-molecular complex of peptide, MHC molecule and TCR.
Further investigations of the use of SVM for T-cell epitope
prediction are warranted as a potentially efficient and power-
ful method for defining candidate autoantigens, finding the
antigenic targets and molecular mimics in complex infectious
organisms, and developing vaccines for infectious diseases
and cancers.
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